Status: current, Defined. Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3901935014 | Product containing only tazemetostat in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3901936010 | Tazemetostat only product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tazemetostat only product in oral dose form | Is a | Tazemetostat only product | true | Inferred relationship | Some | ||
| Tazemetostat only product in oral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Tazemetostat only product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Tazemetostat only product in oral dose form | Is a | Tazemetostat-containing product in oral dose form | true | Inferred relationship | Some | ||
| Tazemetostat only product in oral dose form | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Tazemetostat only product in oral dose form | Has active ingredient | Tazemetostat | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tazemetostat (as tazemetostat hydrobromide) 200 mg oral tablet | Is a | True | Tazemetostat only product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR